infinium cytosnp 850 (Illumina Inc)
Illumina Inc is a verified supplier 
95
Structured Review
Illumina Inc
infinium cytosnp 850
Infinium Cytosnp 850, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/illumina+microarray+platform/Infinium+CytoSNP-850K+v1%2E2+Beadchip+Kit/pm34358677-119-8-7
Average 95 stars, based on 74 article reviews
Infinium Cytosnp 850, supplied by Illumina Inc, used in various techniques. Bioz Stars score: 95/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/illumina+microarray+platform/Infinium+CytoSNP-850K+v1%2E2+Beadchip+Kit/pm34358677-119-8-7
Average 95 stars, based on 74 article reviews
infinium cytosnp 850 - by Bioz Stars,
2026-09
95/100 stars
Images
Related Articles
other:Article Title: Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours. Article Snippet: Published Online xxx https://doi.org/10.. 1016/j.ebiom.2025.. 105643 Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours Chiel F. Ebbelaar,a,b,∗ Anne M. L. Jansen, Leonie C. M. Speet, Frans Schutgens, Sietske Zoetemeyer, Anne-Marie Cleton-Jansen, Marijke R. van Dijk, Gerben E. Breimer, Lourens T. Bloem, Wendy W. J. de Leng, Remco van Doorn, Karijn P. M. Suijkerbuijk, Anne M. R. Schrader, and Willeke A. M. Blokx, MOLecular Evaluation of Melanocytic Ambiguous Tumours (MOLEMAT) Investigators Article Title: Genetic correlates in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with Hyper-CVAD plus dasatinib or ponatinib Article Snippet: Eighty samples were profiled using an Article Title: Clinical outcomes and genomic profiles of MAP2K1 -mutated primary cutaneous melanocytic tumours Article Snippet: Copy number variation (CNV) analysis was conducted using the Article Title: SNP array analysis facilitates the identification of novel chromosomal alterations associated with disease and SNPs related to adverse drug reactions in neuroblastoma Article Snippet: Sample analyses were performed using the Infinium Software:Article Title: The Expression of a Germline Fusion Gene Involving a Protein-Coding and a Long Non-Coding RNA Gene Results in Severe Brain Malformations Article Snippet: Some of the cultures were pre-treated with puromycin solution (catalog no. P8833, Sigma-Aldrich, Burlington, MA, USA) to inhibit nonsense-mediated mRNA decay (NMD), according to the standard operating procedure (SOP) “RNA Analyse nach KurzzeitKul_Trizol_isol” of our institute. .. Copy number variation analysis was performed using the Amplification:Article Title: A comparison of CDKN2A status in gliomas using different techniques: The loss of p16 as a surrogate marker. Article Snippet: The presence of a CDKN2A homozygous deletion (HD) plays an important role in the diagnostic approach for neuropathologists and the clinical prognostic stratification of several CNS tumors.. CDKN2A is located on chromosome 9p21 next to CDKN2B and MTAP and encodes for the protein p16.. Various molecular diagnostics are routinely used for assessing the deletion. Genome Wide:Article Title: Hyperinsulinemia in Sotos Syndrome with a de novo NSD1 Deletion Article Snippet: DNA was quantified using the Nanodrop 1000 Spectrophotometer (Thermo Scientific, Waltham, MA, USA). .. CMA or genome-wide genotyping used for detection of CNVs was performed with the |